Original Research
Accepted on 26 Aug 2025
SRC Is a Potential Target of Arctigenin in Treating Triple-Negative Breast Cancer: Based on Machine Learning Algorithms, Molecular Modeling and in Vitro Test
in Biological Modeling and Simulation
Original Research
Accepted on 26 Aug 2025
in Biological Modeling and Simulation
Original Research
Accepted on 26 Aug 2025
in Neonatology
Original Research
Accepted on 26 Aug 2025
in Nutritional Epidemiology
Original Research
Accepted on 26 Aug 2025
in Nutritional Epidemiology
Review
Accepted on 26 Aug 2025
in Radiopharmacy and Radiochemistry
Systematic Review
Accepted on 26 Aug 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Aug 2025
in Sustainable Pest and Disease Management
Brief Research Report
Accepted on 26 Aug 2025
in Primary Immunodeficiencies
Review
Accepted on 26 Aug 2025
in Integrative and Regenerative Pharmacology
Original Research
Accepted on 26 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Aug 2025
in Circular Economy
Original Research
Accepted on 26 Aug 2025
in Science and Environmental Communication
Original Research
Accepted on 26 Aug 2025
in Immunological Tolerance and Regulation
Perspective
Accepted on 26 Aug 2025
in Public Health Policy
Original Research
Accepted on 26 Aug 2025
in Phage Biology
Original Research
Accepted on 26 Aug 2025
in Life-Course Epidemiology and Social Inequalities in Health